Evidence map›Paper›PMID 30739959›Full record

ArticleTetrahedron2019

Synthesis of amorpha-4,11-diene from dihydroartemisinic acid.

Geoffrey Schwertz, Andrea Zanetti, Marllon Nascimento de Oliveira, Mario Andrès Gomez Fernandez, Fabienne Dioury, Janine Cossy, Zacharias Amara

Open access · hybridAbstract read
In one paragraph

Article in Tetrahedron, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthesis of [3,3-Journal of natural products · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Geoffrey SchwertzLaboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), UMR 8231, ESPCI ParisTech/CNRS/PSL Research University, Paris Cedex 05, France.
Andrea ZanettiLaboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), UMR 8231, ESPCI ParisTech/CNRS/PSL Research University, Paris Cedex 05, France.
Marllon Nascimento de OliveiraLaboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), UMR 8231, ESPCI ParisTech/CNRS/PSL Research University, Paris Cedex 05, France.
Mario Andrès Gomez FernandezLaboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), UMR 8231, ESPCI ParisTech/CNRS/PSL Research University, Paris Cedex 05, France.
Fabienne DiouryEquipe de Chimie Moléculaire, Laboratoire GBCM, EA7528, Conservatoire National des Arts et Métiers, HESAM Université, 2 rue Conté, 75003, Paris, France.
Janine CossyLaboratoire de Chimie Organique, Institute of Chemistry, Biology and Innovation (CBI), UMR 8231, ESPCI ParisTech/CNRS/PSL Research University, Paris Cedex 05, France.
Zacharias AmaraEquipe de Chimie Moléculaire, Laboratoire GBCM, EA7528, Conservatoire National des Arts et Métiers, HESAM Université, 2 rue Conté, 75003, Paris, France.
Conservatoire National des Arts et Métiers · FRUniversité Paris Sciences et Lettres · FRCentre National de la Recherche Scientifique · FRESPCI Paris · FRHESAM Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amorphadiene is a natural product involved in the biosynthesis of the antimalarial drug artemisinin. A convenient four-step synthesis of amorphadiene, starting from commercially available dihydroartemisinic acid, is reported. The targeted molecule is isolated with an overall yield of 85% on a multi-gram scale in four steps with only one chromatography.

Indexed as

AmorphadieneArtemisininEliminationMalariaMicrowaves

Identifiers

PMID30739959
PMCPMC6346372
OpenAlexW2905883959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.